Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,709.60
(
0.00%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
92.96
(
-3.14%
)
Bitcoin
69,978.99
(
-1.95%
)
News Focus
News Focus
Post# of 828659
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Chiugray

Send PM Follow Ignore
Followers 79
Posts 2339
Boards Moderated 0
Alias Born 01/31/2014

Chiugray

Re: Slave1 post# 775262

Friday, 07/11/2025 1:33:19 AM

Friday, July 11, 2025 1:33:19 AM

Post# of 828659
Slave1, That is really good insight, pulling many things together. Very sharp of you. So the Mayo clinic DC trials are covered by NWBO patents, and therefore the Mill Creek Life Sciences IP is as well.

This is becoming more and more apparent that NWBO's IP and moat for DC therapy holds a dominant position. Novel treatment discoveries and strategies may come to realize
- their medicine can be greatly enhanced with DCVax, and/or
- if they work with DCs, realize that their commercial path leads to licensing rights with NWBO.
Bullish
Bullish

Sharing thoughts and opinions. To participate in group due diligence. Motto: Do not be a gullible FUDdable investor.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News